Immune activation in chronic heart failure and the role of endotoxin

ISRCTN ISRCTN21486547
DOI https://doi.org/10.1186/ISRCTN21486547
Secondary identifying numbers N0201082084
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
28/02/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Philip A Poole-Wilson
Scientific

Imperial College School of Medicine NHLI
Guy Scadding Building
Dovehouse Street
London
SW3 6LY
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific titleImmune activation in chronic heart failure and the role of endotoxin
Study objectivesTo investigate whether CHF is associated with immune dysregulation and to establish whether endotoxin levels are increased in heart failure patients and whether an endotoxin challenge is a component of immune activation in patients with severe CHF. Study could lead to new therapeutic insights and could contribute to the development of new therapeutic strategies for immune activation in CHF and a syndrome currently without effective treatment ie cardiac cachexia.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCardiovascular: Chronic heart failure
InterventionStudy A: Randomised Controlled Trial (10 cachetic and 10 non-cachetic stable CHF patients, and 10 controls)
Study B: Cohort Observation (10 CHF patients presenting acute oedematous exacerbation)
Intervention typeOther
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/04/1997
Completion date29/06/2006

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants20
Key inclusion criteriaNot provided at time of registration
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/04/1997
Date of final enrolment29/06/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Imperial College School of Medicine NHLI
London
SW3 6LY
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government

The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Royal Brompton and Harefield NHS Trust (UK) Joint Committee for Research

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 29/05/1999 28/02/2020 Yes No

Editorial Notes

28/02/2020: Publication reference added.